| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-4362.1990.TB04755.X |
| P698 | PubMed publication ID | 2141830 |
| P2093 | author name string | A Dompmartin | |
| J P Coulaud | |||
| E Grosshans | |||
| A M Deluol | |||
| D Dompmartin | |||
| P433 | issue | 5 | |
| P921 | main subject | laboratory | Q483242 |
| P304 | page(s) | 337-339 | |
| P577 | publication date | 1990-06-01 | |
| P1433 | published in | International Journal of Dermatology | Q15752742 |
| P1476 | title | Onychomycosis and AIDS. Clinical and laboratory findings in 62 patients | |
| P478 | volume | 29 |
| Q70502533 | Clinical pearl: proximal white subungual onychomycosis in AIDS |
| Q41718745 | Current issues in onychomycosis |
| Q42200063 | Cutaneous manifestations of HIV-a detailed study of morphological variants, markers of advanced disease, and the changing spectrum |
| Q35544197 | Epidemiology, clinical presentation and diagnosis of onychomycosis |
| Q68003912 | Extensive dermatophytoses caused by Trichophyton mentagrophytes and Microsporum canis in a patient with AIDS |
| Q41428904 | Fungal disease in the immunocompromised host |
| Q70843395 | Guidelines of care for superficial mycotic infections of the skin: onychomycosis. Guidelines/Outcomes Committee. American Academy of Dermatology |
| Q34056471 | HIV disease: mucocutaneous fungal infections in HIV disease |
| Q41091930 | HIV-related skin diseases |
| Q41349375 | Human immunodeficiency virus in women: mucocutaneous manifestations |
| Q40697996 | Management of common superficial fungal infections in patients with AIDS. |
| Q33726217 | Management of onychomycoses |
| Q71567332 | Nail infections |
| Q46703627 | Non-dermatophytic moulds: onychomycosis in four patients infected with the human immunodeficiency virus |
| Q74666793 | Once-weekly fluconazole in the treatment of onychomycosis: introduction |
| Q35544201 | Onychomycosis in clinical practice: factors contributing to recurrence |
| Q34000895 | Onychomycosis in the elderly |
| Q33975323 | Onychomycosis: pathogenesis, diagnosis, and management |
| Q41958182 | Orocutaneous Manifestations as Markers of Disease Progression in HIV Infection in Indian Setting |
| Q35827685 | Patient considerations in the management of toe onychomycosis - role of efinaconazole |
| Q35422560 | Proximal Subungual Onychomycosis in a Patient with Classic Kaposi Sarcoma Caused by Trichophyton rubrum |
| Q71820503 | Proximal White Subungual Onychomycosis in a Kideny Transplant Patient |
| Q72695432 | Proximal white subungual onychomycosis: a sign of immunodeficiency |
| Q52033210 | Quality of life of persons with onychomycosis. |
| Q50934324 | Study of onychomycosis in Córdoba, Spain: prevailing fungi and pattern of infection. |
| Q33569526 | Terbinafine. A pharmacoeconomic evaluation of its use in superficial fungal infections |
| Q40470751 | The epidemiology of onychomycosis in Britain |
| Q33224151 | The spectrum of nail disease in patients with human immunodeficiency virus infection |
| Q43665084 | Unusual Microsporum canis infections in adult HIV patients |
| Q34458634 | Which antifungal agent for onychomycosis? A pharmacoeconomic analysis |
Search more.